Search Results 1061-1070 of 16308 for Chronic Lymphocytic Leukemia
BCR-ABL-positive leukemia (chronic myelogenous leukemia in blast crisis). Diagnosis of acute promyelocytic leukemia (M3 AML or APML). Second malignancy ...
The purpose of this study is to create a biorepository for samples of chronic pain patients. Participation eligibility. Participant eligibility includes age, ...
The process of diagnosis usually starts with a medical history review and a ... Related. Brain tumor FAQs · Living with Brain Tumors · Long Term Brain Cancer ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
- Diagnosis of acute promyelocytic leukemia (APL M3): t(15;17)(q22;q12); (promyelocytic leukemia [PML]/retinoic acid receptor [RAR] alpha [a]) and variants ...
Some people, including African Americans, Native Americans and Asian Americans, are at higher risk of developing chronic kidney disease. March 11 is World ...
... diagnosis. If the patient is refractory to first line of treatment, a ... chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter transformation).
The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...
... chronic myelogenous leukemia (CML or BCR/ABL), are not eligible; Patients must have disease present in the blood or bone marrow; patients with only ...
The purpose of this study is to rigorously examine whether patient capacity at baseline is predictive of multiple outcomes of interest to patients, clinicians, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.